| Pharmaceutical active ingredients: |
| Flufenamic Acid |
| Available forms, composition and doses of Ansatin: |
| N / A |
| Ansatin medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AG03 - Flufenamic acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Anprolene | Ethylene Oxide | Unidentified Pharmaceutical Company |
| Anproline | Ethylene Oxide | Unidentified Pharmaceutical Company |
| Anpuzone | Phenylbutazone | Unidentified Pharmaceutical Company |
| Ansamycin | Rifabutin | Unidentified Pharmaceutical Company |
| Ansaron | Diuron | Unidentified Pharmaceutical Company |
| Anscor P | Magnesium Oxide | Unidentified Pharmaceutical Company |
| Ansepron | Phenprobamate | Unidentified Pharmaceutical Company |
| Ansiatan | Meprobamate | Unidentified Pharmaceutical Company |
| Ansietan | Meprobamate | Unidentified Pharmaceutical Company |
| Ansil | Meprobamate | Unidentified Pharmaceutical Company |